HCPS

CollegeVine and Henrico County Public Schools Partner to Redefine the College Admissions Process for Students and Counselors

Retrieved on: 
Tuesday, November 28, 2023
Primary, Secondary, Professional Services, Education, Other Education, Consulting, University, Research, Student, Letter, HCPS, Counselor, School, Partnership, Henrico County Public Schools, Tutoring

CollegeVine today announced a partnership with Henrico County Public Schools (HCPS) to redefine college preparation for both students and counselors in the district.

Key Points: 
  • CollegeVine today announced a partnership with Henrico County Public Schools (HCPS) to redefine college preparation for both students and counselors in the district.
  • The collaboration between CollegeVine and HCPS is centered around providing students and school counselors access to CollegeVine’s network of over 2 million students and 400+ colleges.
  • CollegeVine is a comprehensive platform designed to guide students through every aspect of their journey after high school.
  • Zack Perkins, CollegeVine’s chief executive officer, said of the partnership, "We’re thrilled to partner with Henrico County to bring free, equitable access to college opportunities for Virginia students.

The Academy of Interpretation (AOI) Partners with Harrisonburg City Public Schools to Empower Future Interpreters

Retrieved on: 
Tuesday, November 14, 2023
Assistant, Education, HCPS, Secondary school, Language, Student, Gap, Harrisonburg High School, Harrisonburg City Public Schools, Interpretation, AOI, Partnership, Communication, Growth, Language interpretation, Knowledge

HARRISONBURG, Va., Nov. 14, 2023 /PRNewswire/ -- The Academy of Interpretation (AOI), an organization dedicated to advancing the language services industry by setting high-quality interpreter standards and promoting education and experience, is excited to announce its partnership with Harrisonburg City Public Schools (HCPS).

Key Points: 
  • HARRISONBURG, Va., Nov. 14, 2023 /PRNewswire/ -- The Academy of Interpretation (AOI), an organization dedicated to advancing the language services industry by setting high-quality interpreter standards and promoting education and experience, is excited to announce its partnership with Harrisonburg City Public Schools (HCPS).
  • In an initiative to foster the growth of aspiring interpreters, the AOI has awarded scholarships to HCPS's High School's Interpreters club members.
  • The AOI's partnership with Harrisonburg City Public Schools demonstrates their shared commitment to nurturing talent and setting standards within the language services industry.
  • For more information about the Academy of Interpretation (AOI) and their initiatives, please visit academyofinterpretation.com .

Genetic Technologies to Launch Ground-breaking Comprehensive Risk Test for Breast & Ovarian Cancer

Retrieved on: 
Monday, February 6, 2023
Laboratory developed test, Breast, CLIA, ASX, Genetypes, BRCA, Health professional, Accreditation, HCPS, Patient, Certification, NATA, FDA, CIT, GTG, Test, LDT, Research, Pharmaceutical industry, Medical device

GTG is in discussions with a range of US payers regarding the adoption of the geneType breast cancer risk assessment test.

Key Points: 
  • GTG is in discussions with a range of US payers regarding the adoption of the geneType breast cancer risk assessment test.
  • A principal reason for the development of this test has directly emerged from our discussions with these groups as it was a test they were seeking.
  • It is our intention to also offer the Comprehensive Risk test for breast and ovarian cancer through this channel, noting that the channel already exists.
  • GTG will be initiating promotion of the Comprehensive Risk test for breast and ovarian cancer through these channels in the coming weeks as part of our commercialization strategy and the test will be showcased at the BRCA 2023 Symposium in Montreal in late May.

H1 is Named to the New York Digital Health 100 For Second Straight Year

Retrieved on: 
Wednesday, February 1, 2023
Universe, Female, Global health, Digital health, HCPS, Medical Affairs Bureau, Patient, Library and information science, Success, Growth, Organization, Digital, Pharmaceutical industry, H1

NEW YORK, Feb. 01, 2023 (GLOBE NEWSWIRE) -- H1 , the connecting force for global healthcare providers, today announced that it has been named to the New York Digital Health 100 (DH100) for the second year in a row.

Key Points: 
  • NEW YORK, Feb. 01, 2023 (GLOBE NEWSWIRE) -- H1 , the connecting force for global healthcare providers, today announced that it has been named to the New York Digital Health 100 (DH100) for the second year in a row.
  • Digital Health New York (DHNY) publishes the annual list as part of its New York Healthcare Innovation Report, a comprehensive analysis that takes an in-depth look at the data, trends, and people that have propelled New York to become the capital of healthcare innovation.
  • “I speak for everyone at H1 when I say that we are proud to be recognized, once again, by DHNY as a top digital health company,” said Ariel Katz , co-founder and CEO at H1.
  • We are determined to improve global health equity by making access to accurate healthcare information a basic human right.

Wearable ECG Devices Global Market Report 2022: Increasing Usage of Advanced Sensors & Artificial Intelligence Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, January 13, 2023
Medical Devices, Health, Samsung Galaxy Watch 3, Artificial intelligence, Hospital, Reading, ML, Communication, Heart, Apple Watch, Arrhythmia, FDA, Apple Watch Series 4, Holter, Electrocardiography, AI, ECG, Alivecor, Diagnosis, Growth, Fitbit, HCPS, Electronics, Software, DL, Atrial fibrillation, Clothing, AF, Acquisition, EKG, Medical device, Medical imaging

The "Wearable ECG Devices Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Wearable ECG Devices Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • The emergence of advanced sensors, AI, ML, and DL in wearable ECG is boosting the wearable ECG devices market.
  • Such integration of ECG with smartwatches contributes to the growth of the wearable ECG devices market.
  • Owing to the benefits of ambulatory monitoring, wearable ECG devices market players are significantly focusing on developing user-friendly, safe & accurate ambulatory ECG devices.

Conduent Launches Digital Solution to Help Pharmas with Faster and More Effective Product Commercialization

Retrieved on: 
Thursday, January 12, 2023
HCP, Organization, Marketing, ROI, HCPS, Conduent, Risk, Pharmacotherapy, Fine chemical

FLORHAM PARK, N.J., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Conduent Incorporated (Nasdaq: CNDT), a global technology-led business process solutions company, today announced the launch of the IntelliHealth module for healthcare provider engagement. This new module is an end-to-end solution to help pharma organizations improve access to, and increase engagement with, healthcare professionals to drive focused pharmaceutical sales and marketing. IntelliHealth enables pharma organizations to power faster and more effective product commercialization with advanced analytics, omnichannel communication and experienced sales professionals and medical science liaisons. The robust platform delivers highly flexible hybrid engagement models that enable pharma organizations to reduce risk, manage costs and gain competitive advantages while driving ROI across the full life cycle of a drug therapy.

Key Points: 
  • This new module is an end-to-end solution to help pharma organizations improve access to, and increase engagement with, healthcare professionals to drive focused pharmaceutical sales and marketing.
  • IntelliHealth enables pharma organizations to power faster and more effective product commercialization with advanced analytics, omnichannel communication and experienced sales professionals and medical science liaisons.
  • The next-generation technology is matched with the company’s proven experience in delivering emergent campaigns, via remote and digital engagement, to create a seamless experience for HCPs.
  • Our pharma clients require HCP engagement models that advance their brands in a fast-changing and complex landscape,” said Randall King, President, Commercial Solutions at Conduent.

MTD GROUP: AN INNOVATIVE SAFETY NEEDLE WITH FULLY PASSIVE MECHANISM, RECEIVED FDA CLEARANCE

Retrieved on: 
Wednesday, January 11, 2023
Injury, Failure, Certification, CPH, Vaccination, NSIS, SARS-COV-2, HCPS, Risk, CE, HCP, Patient, Health, Systematic review, Safety, FDA, MTD, Vaccine, MPH, Doctor of Public Health, COVID, Pharmaceutical industry

Despite broad introduction of safety regulations over the last decades, it is estimated that more than 2 million NSIs still occur each year[1].

Key Points: 
  • Despite broad introduction of safety regulations over the last decades, it is estimated that more than 2 million NSIs still occur each year[1].
  • "Moving towards safer medical device technology –and especially evolving sharps with injury prevention features to a more passive design– promises to reduce needlestick injuries.
  • Safety device designs that require a user to actively do something can result in injury during activation, or failure to activate the safety feature at all.
  • A fully passive injection device such as the DropSafeTM SicuraTM, fulfills an unmet need of our customers in the US for increased safety.

MTD GROUP: AN INNOVATIVE SAFETY NEEDLE WITH FULLY PASSIVE MECHANISM, RECEIVED FDA CLEARANCE

Retrieved on: 
Wednesday, January 11, 2023
Injury, Failure, Certification, CPH, Vaccination, NSIS, SARS-COV-2, Multimedia, HCPS, Risk, CE, HCP, Patient, Health, Systematic review, Safety, FDA, MTD, Vaccine, MPH, Doctor of Public Health, COVID, Pharmaceutical industry

Despite broad introduction of safety regulations over the last decades, it is estimated that more than 2 million NSIs still occur each year[1].

Key Points: 
  • Despite broad introduction of safety regulations over the last decades, it is estimated that more than 2 million NSIs still occur each year[1].
  • "Moving towards safer medical device technology –and especially evolving sharps with injury prevention features to a more passive design– promises to reduce needlestick injuries.
  • Safety device designs that require a user to actively do something can result in injury during activation, or failure to activate the safety feature at all.
  • A fully passive injection device such as the DropSafeTM SicuraTM, fulfills an unmet need of our customers in the US for increased safety.

Accord BioPharma Announces AccordConnects Inventory Management System for Hospitals and Healthcare Practices

Retrieved on: 
Tuesday, January 10, 2023
Computer, Google Play, Software, Hospital, Biology, App store, Intas Biopharmaceuticals, HCPS, Accord, Marketing, Biopharma LLC, Online shopping

DURHAM, N.C., Jan. 10, 2023 /PRNewswire/ -- Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on development of oncology, immunology, and critical care therapies, today announced the launch of a mobile app and web-based inventory management capability, AccordConnects, which helps healthcare practices track inventory of Accord BioPharma therapies.

Key Points: 
  • DURHAM, N.C., Jan. 10, 2023 /PRNewswire/ -- Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on development of oncology, immunology, and critical care therapies, today announced the launch of a mobile app and web-based inventory management capability, AccordConnects, which helps healthcare practices track inventory of Accord BioPharma therapies.
  • AccordConnects allows hospitals and healthcare practices to register Accord BioPharma products that they've received in a secure online database, create a link between their Accord BioPharma product inventory and a practice's electronic health record system, view alerts to enable optimal product lifecycle decisions, and keep a record of when inventory has been dispensed.
  • Now, it will provide most of those same capabilities on a website created by Accord BioPharma in addition to—and in concert with—the mobile version.
  • For these reasons, we worked to make our intuitive, user-friendly inventory management system available wherever was most convenient."

OptimizeRx CEO Issues Open Letter to Shareholders Ahead of Presentation at J.P. Morgan Healthcare Conference

Retrieved on: 
Wednesday, January 4, 2023
POC, Social media, Partnership, HCPS, EHR, Real world evidence, HCP, Patient, Letter, Artificial intelligence, AI, Physician, Conference, ROI, Rois, RWE, Real, Environment, Pharmaceutical industry

The OPRX conference presentation is scheduled to begin at 8:15 AM PT on January 12, 2023.

Key Points: 
  • The OPRX conference presentation is scheduled to begin at 8:15 AM PT on January 12, 2023.
  • Ahead of the conference, OPRX is providing the following business update and key industry trends from management’s presentation.
  • The full letter is published below:
    We are honored to have the opportunity to share our progress and market opportunity as a presenter at J.P. Morgan Healthcare Conference, Wall Street’s most prestigious healthcare conference.
  • We look forward to connecting with everyone at the J.P. Morgan Healthcare Conference and in our next earnings call.